Form 8-K - Current report:
SEC Accession No. 0001393905-20-000310
Filing Date
2020-10-29
Accepted
2020-10-29 16:04:05
Documents
2
Period of Report
2020-10-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT rtsl_8k.htm 8-K 55091
2 ASSET PURCHASE AND SALES AGREEMENT DATED OCTOBER 23, 2020 rtsl_ex21.htm EX-2.1 122670
  Complete submission text file 0001393905-20-000310.txt   179164
Mailing Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240
Business Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240 214-236-1363
Rapid Therapeutic Science Laboratories, Inc. (Filer) CIK: 0001575659 (see all company filings)

IRS No.: 462111820 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-55018 | Film No.: 201272616
SIC: 2834 Pharmaceutical Preparations